Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.
about
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptaseMinority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacyHIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically highReappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infectionA combined screening platform for HIV treatment failure and resistanceHighly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in JapanDecreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivityMinority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCRPersistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgroundsDeep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, BrazilLongitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage TherapySimplified Paper Format for Detecting HIV Drug Resistance in Clinical Specimens by Oligonucleotide LigationSynthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an exampleA system for specific, high-throughput genotyping by allele-specific primer extension on microarrays.Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil.Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment.Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapyChanges in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.Population genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Minority variants of drug-resistant HIV.Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors.Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study.Microarray techniques in pathology: tool or toy?Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence dataHepatitis C virus protease gene diversity in patients coinfected with human immunodeficiency virusReplicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort Study.Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencingPersistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer IDA Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients.Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy.Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.Transmitted HIV drug resistance in treatment-naive Romanian patientsPerformance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms.High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patientsSequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay
P2860
Q24550959-172D074A-A87B-4CB4-820B-74DDB1AA8810Q28473296-A595C971-1470-49A1-BA10-523F885C8C1BQ28476627-11DFCDB2-5023-4473-80D8-B142E4F3A793Q28478934-8FF89FA9-A267-4380-8BCF-76A9C6399316Q28482549-3DBCF6AA-D93D-4D40-90D1-9B9AD3D01C07Q28537608-6F0C2B86-2A9F-456D-A479-B12A8CC0F49DQ28540368-3AA48651-A922-4E9B-9E66-19EE3872D331Q28543986-0E0F2E3A-F08A-45D5-BFC3-00CC266CFB65Q28544845-6CE1FB0B-E6F4-49A8-BB89-50364D96BBD6Q28544988-C3C894A9-F88F-40B5-8BE7-65B8570E863BQ28547874-FE60853B-FC16-4B7B-B9C6-05D44E564066Q28552499-E307FCDF-598D-4F3B-944C-C19CA0CA3678Q30405988-4294927B-DE07-4F28-9BE9-270B9F675FFBQ30651566-47B9E888-2386-4EF3-A904-0E7CA58F8134Q30870822-8DB58952-18C7-41E1-B7CC-72F2CC5792C0Q33243910-8CEFEF64-6240-4279-9DDB-1722E1710B3BQ33592278-BC052370-C069-4A44-BCCF-8364C8BA22E0Q33782492-4127BC68-C683-4627-874E-A36FE07303C2Q33843040-9CB0991B-878D-4977-A38E-DD703F59651DQ33843999-3DAB9552-7F92-4E6A-9459-BA1FFD87EA41Q33906239-761A97E0-08D5-4820-866A-0232E9FEACFFQ34047780-937616AF-3B87-49F2-91DE-DFD8443F3CD7Q34108775-9E9B0703-9A9B-481D-9D4A-8FA5E4803E0BQ34112020-289E366E-733F-40D0-BD06-2496659DA6E3Q34148146-0AF134AE-7E2B-4C9E-A66A-94AC6F6DFDEEQ34205837-DBEFF68A-8277-4EBC-87FF-97EE52354CABQ34545969-2554B0A3-458D-4CFF-ADDB-2B9517A2333EQ34547116-4BFBC3A1-5FA8-4564-A174-D3B81C454DFBQ34567556-DB7388BE-56AA-41AF-B25B-AFF01831A7D0Q34598577-451F28CD-64EE-47E4-A5B9-5FFDEE892F38Q35647691-BEAAACA6-72CA-4C6C-BECA-1C41E15FB51EQ35742512-91F107D1-5512-4D29-BCBF-925525D10D86Q36315090-B76A2CA5-C30D-472E-9207-8941818A1523Q36371754-B8E16840-B479-443A-80A4-DB5D705B3A6DQ36673315-598BE38A-7127-4257-AC58-C0D11A13D118Q37386398-122BEDAA-32E6-4C84-817A-803F98E57C48Q37495405-ADD2C0A5-AA98-4A9C-85D0-FB8CC29C194BQ39451075-D6CC379E-1B84-4224-9BC0-B18B99170354Q39464193-E74A44AA-E1A4-4C45-AA7D-44B1944F8D98Q40909665-8118E1A1-E007-4DFA-86BB-FE3279C7461A
P2860
Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Comparative performance of hig ...... e 1 pol from clinical samples.
@en
Comparative performance of hig ...... e 1 pol from clinical samples.
@nl
type
label
Comparative performance of hig ...... e 1 pol from clinical samples.
@en
Comparative performance of hig ...... e 1 pol from clinical samples.
@nl
prefLabel
Comparative performance of hig ...... e 1 pol from clinical samples.
@en
Comparative performance of hig ...... e 1 pol from clinical samples.
@nl
P2093
P356
P1476
Comparative performance of hig ...... e 1 pol from clinical samples.
@en
P2093
P304
P356
10.1089/AID.1998.14.869
P577
1998-07-01T00:00:00Z